AREQUIPA, Peru and MEXICO CITY, Mexico – Seale & Associates, Inc. announced that it acted as exclusive financial advisor to Invekra, S.A.P.I. de C.V. (“Grupo Invekra”), a Latin American pharmaceutical conglomerate headquartered in Mexico City, on the acquisition of a 51% stake in Laboratorios Portugal, S.R.L. (“Portugal”), a leading manufacturer of pharmaceutical and personal care products in Peru.

“We are pleased to have advised our client on this complex cross-border transaction”, said Carlos Hernandez, Vice President with Seale & Associates. “This acquisition strengthens Invekra’s presence in one of the fastest growing markets in Latin America”.

Grupo Invekra is a conglomerate of 12 Latin American pharmaceutical companies, including Laboratorios Sanfer, with presence in 10 countries across Latin America. It employs more than 6,000 people and manufactures, markets, and sells prescription and OTC branded medications across 10 therapeutic areas.

Laboratorios Portugal is a pharmaceutical and personal care company with more than 150 years of experience in the Peruvian market. It has a highly-diversified portfolio that offers more than 700 products. Portugal’s brands include Naturgen, which offers generic drugs, Bahia Solar, its line of sunblock products, and Portugal Cosmetics, which offers soaps and other personal care products.

Seale & Associates, Inc., headquartered in Arlington, Virginia, is a global investment banking firm with extensive experience in mergers and acquisitions, corporate finance advisory, and enterprise level strategy consulting. Our professionals are trusted advisors maintaining a high level of quality and integrity while presenting innovative ideas and solutions to address our clients’ most complex dealings. Seale Capital, Inc., an affiliate of Seale & Associates, Inc., is a registered broker dealer and member of FINRA and SIPC. All securities related transactions are cleared through Seale Capital. For more information, please visit www.sealeassociates.com.